Company news

Curasight A/S news in 2025

Curasight A/S's news releases, calls and decks from 2025, newest first.

View company

Curasight A/S resolves to issue a convertible loan note

December 29, 2025

Curasight Announces Successful Dosing of First Patient in Phase 1 trial with uTREAT® in Brain Cancer

December 18, 2025

Curasight announces acceptance of clinical trial application (CTA) for phase 1 trial with uTREAT® in brain cancer patients

August 26, 2025

Decks in 2025